These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12111701

  • 21. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 22. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R.
    J Clin Oncol; 2004 Aug 01; 22(15):3104-12. PubMed ID: 15284261
    [Abstract] [Full Text] [Related]

  • 23. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 01; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 24. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 01; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [Abstract] [Full Text] [Related]

  • 25. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug 01; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 26. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR, Shafiei N, Safarinejad S.
    Growth Horm IGF Res; 2011 Jun 01; 21(3):146-54. PubMed ID: 21536469
    [Abstract] [Full Text] [Related]

  • 27. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov 01; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 28. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 29. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM.
    J Am Geriatr Soc; 2008 Apr 01; 56(4):652-60. PubMed ID: 18312313
    [Abstract] [Full Text] [Related]

  • 30. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1290-5. PubMed ID: 15298948
    [Abstract] [Full Text] [Related]

  • 31. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.
    Gastroenterology; 2005 Aug 01; 129(2):464-75. PubMed ID: 16083703
    [Abstract] [Full Text] [Related]

  • 32. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct 01; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 33. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C, Freeman R, Voigt LF, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2461-6. PubMed ID: 17164371
    [Abstract] [Full Text] [Related]

  • 34. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE.
    Asian J Androl; 2008 Mar 01; 10(2):207-13. PubMed ID: 18097534
    [Abstract] [Full Text] [Related]

  • 35. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar 01; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 36. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
    Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D.
    Urology; 2004 Aug 01; 64(2):317-22. PubMed ID: 15302487
    [Abstract] [Full Text] [Related]

  • 37. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk.
    Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X.
    J Urol; 2003 Feb 01; 169(2):714-7. PubMed ID: 12544349
    [Abstract] [Full Text] [Related]

  • 38. A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
    Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Czernichow S, Hercberg S.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 01; 14(9):2269-72. PubMed ID: 16172243
    [Abstract] [Full Text] [Related]

  • 39. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun 01; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 40. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr 01; 16(4):763-8. PubMed ID: 17416768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.